Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Roundtable Interview: Daniel Aletaha, Andrew Cope, and Mwidimi Ndosi
6
Mins
July 2024
It has been very difficult to choose an abstract for this conference, you can tell by my choice that I think understanding the impact…
Read more
11
Mins
29th July 2019
Secukinumab in the Management of Psoriatic Arthritis: Current Perspectives
Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…
8
Mins
29th July 2019
A Review of Adalimumab Biosimilars for the Treatment of Immune-Mediated Rheumatic Conditions
Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…
5
Mins
29th July 2019
Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities
Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…
9
Mins
13th December 2018
Central Processes Underlying Fibromyalgia
Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…
9
Mins
13th December 2018
Drilling Down to the Bone: Evaluating Bone Marrow Lesions in Osteoarthritis
Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…
9
Mins
13th October 2018
Effect of Mesenchymal Stem Cells in Autoimmune Arthritis
The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…
10
Mins
4th September 2018
Switching from Reference to Biosimilar Products: An Overview of the European Approach and Real-World Experience So Far
Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…
9
Mins
4th September 2018
Knee Infection After Anterior Cruciate Ligament Reconstruction
This article presents a case of infection after ACL reconstruction and discusses risk factors, treatment choice, antibiotic treatment length, and functional outcomes, proposing a guide for the treatment.
Loading posts...
« Previous
1
…
9
10
11
12
13
…
20
Next »